Overview

Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Pregabalin added to the standard of care with dosing starting preoperatively and continuing for up to 6 weeks post surgery will decrease the intensity of post-operative pain following total knee replacement.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin